Global Cryptococcal Meningitis Screening

global health
Global Cryptococcal Meningitis Screening
To determine feasibility and cost of prevention of Cryptococcal disease in African, Asian and Central American countries via the implementation of a “screen-and-treat” strategy. This strategy will support and guide policy makers in the rollout and sustained management of a successful “screen-and-treat” program. This project is expanding to an additional 8-12 countries.
Pfizer Inc.
CDC's National Center for Emerging and Zoonotic Infectious Diseases
Subscribe to Zoonotic Disease